These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3297965)

  • 21. Hyperthyroidism due to a thyrotropin-secreting pituitary adenoma. Studies of thyrotropin and subunit secretion.
    Smith CE; Smallridge RC; Dimond RC; Wartofsky L
    Arch Intern Med; 1982 Sep; 142(9):1709-11. PubMed ID: 6810781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman.
    Custro N; Scafidi V; Notarbartolo A
    J Endocrinol Invest; 1992 Feb; 15(2):121-6. PubMed ID: 1569287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
    Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
    Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
    J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Diagnostic and therapeutic considerations.
    Smallridge RC; Smith CE
    Arch Intern Med; 1983 Mar; 143(3):503-7. PubMed ID: 6338852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy.
    Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypophyseal hyperthyroidism. Non-tumoral hypersecretion of thyroid stimulating hormone with clinical hyperthyroidism].
    Bregengård C; Eigtved AI; Siersbaek-Nielsen K
    Ugeskr Laeger; 1989 Dec; 151(50):3404-5. PubMed ID: 2609451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inappropriate thyrotropin secretion. Part 2: non tumoral (author's transl)].
    Hamon P; Baulieu JL; Doumith R; Jambart S; Turpin G
    Nouv Presse Med; 1981 Jun; 10(28):2361-4. PubMed ID: 6791128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin.
    Terzolo M; Orlandi F; Bassetti M; Medri G; Paccotti D; Cortelazzi D; Angeli A; Beck-Peccoz P
    J Clin Endocrinol Metab; 1991 Feb; 72(2):415-21. PubMed ID: 1704010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.
    Ridgway EC; Weintraub BD; Cevallos JL; Rack MC; Maloof F
    J Clin Invest; 1973 Nov; 52(11):2783-92. PubMed ID: 4201265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thyrotropin secreting adenoma].
    Kamio M
    Nihon Rinsho; 1993 Oct; 51(10):2701-5. PubMed ID: 8254942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
    Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M; Fortunato M; Molteni L; Peretti E; Mortini P
    Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Resistance to thyroid hormone and Hashimoto's thyroiditis].
    Guerra-Argüero LM; Gutiérrez-Saucedo JA; Gómez-Coello A; Gállego-Suárez C; Vázquez Mellado-Septién A
    Cir Cir; 2011; 79(5):453-7. PubMed ID: 22385766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin-secreting pituitary adenomas: report of seven cases.
    Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
    J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unusual case of inappropriate secretion of thyrotropin: neoplastic or nonneoplastic?
    Castro MR; Kocher D; Morris JC
    Endocr Pract; 2000; 6(1):29-33. PubMed ID: 11419924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma.
    Gasparoni P; Rubello D; Persani L; Beck-Peccoz P
    Thyroid; 1998 Feb; 8(2):181-3. PubMed ID: 9510128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical impact of the thyrotropin-releasing hormone test.
    Faglia G
    Thyroid; 1998 Oct; 8(10):903-8. PubMed ID: 9827657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.